Identification of consistent novel submegabase deletions in low‐grade oligodendrogliomas using array‐based comparative genomic hybridization

We have analyzed 18 low‐grade gliomas using array comparative genomic hybridization (aCGH) with an average resolution of <500 kb. Because the majority of these tumors showed loss of chromosome arms 1p and 19q, we used custom statistical approaches to define submegabase hemizygous losses throughout the genome that correlated with 19q loss. As a result of this analysis, we have identified a ∼550‐kb region in 11q13 and a ∼300‐kb region in 13q12 that showed hemizygous deletion in virtually all the tumors analyzed regardless of their 1p/19q status. FISH analyses of interphase nuclei from the same tumors used for aCGH analysis confirmed the hemizygous loss. The identification of such specific changes provides a potentially very useful diagnostic marker for this subgroup of low‐grade tumors. These regions of the genome define small numbers of candidate genes that are within the deletions. The aCGH analysis also defined the spectrum of gain and loss of genomic regions in low‐grade oligodendrogliomas. © 2005 Wiley‐Liss, Inc.

[1]  B. Fisher,et al.  Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  N. Nowak,et al.  High-resolution analysis of genetic events in cancer cells using bacterial artificial chromosome arrays and comparative genome hybridization. , 2003, Advances in cancer research.

[3]  S. Matsui,et al.  Disappearance of a structural chromatin protein A24 in mitosis: implications for molecular basis of chromatin condensation. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K. Aldape,et al.  Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. , 2002, Cancer research.

[5]  B. Scheithauer,et al.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Acebes,et al.  Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas , 2003, Cancer.

[7]  B. Feuerstein,et al.  Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas , 2005, Genes, chromosomes & cancer.

[8]  K. Aldape,et al.  Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  M. Wigler,et al.  Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.

[10]  R. Mccomb,et al.  Pathology and Genetics of Tumours of the Nervous System , 1998 .

[11]  D. Louis,et al.  Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19. , 2002, Cancer research.

[12]  S. Matsui,et al.  Quantitative conservation of chromatin-bound RNA polymerases I and II in mitosis. Implications for chromosome structure , 1979, The Journal of cell biology.

[13]  N. Nowak,et al.  Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme. , 2004, Cancer genetics and cytogenetics.

[14]  B. Scheithauer,et al.  Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Daniel Pinkel,et al.  Genomic microarrays in human genetic disease and cancer. , 2003, Human molecular genetics.

[16]  D. Louis,et al.  Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. , 2000, Journal of neurosurgery.

[17]  J. Cowell,et al.  Molecular definition of chromosome translocations involving 10q24 and 19q13 in human malignant glioma cells. , 1998, Cancer genetics and cytogenetics.

[18]  V P Collins,et al.  Brain tumours: classification and genes , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  Jane Fridlyand,et al.  Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. , 2005, Human molecular genetics.

[20]  M. Zeviani,et al.  Defects of Mitochondrial DNA , 1992, Brain pathology.

[21]  G. Barnett,et al.  Characterization of the 1p/19q Chromosomal Loss in Oligodendrogliomas Using Comparative Genomic Hybridization Arrays (CGHa) , 2004, Journal of neuropathology and experimental neurology.

[22]  J. Rey,et al.  Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors , 1995, International journal of cancer.

[23]  B. Scheithauer,et al.  The New WHO Classification of Brain Tumours , 1993, Brain pathology.

[24]  Ajay N. Jain,et al.  Assembly of microarrays for genome-wide measurement of DNA copy number , 2001, Nature Genetics.

[25]  S. S. Young,et al.  Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .

[26]  D. Louis,et al.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.

[27]  R. Fimmers,et al.  Oligodendroglial Tumors: Refinement of Candidate Regions on Chromosome Arm 1p and Correlation of 1p/19q Status with Survival , 2004, Brain pathology.

[28]  W. Shapiro,et al.  Low-grade glioma: Supratentorial astrocytoma, oligodendroglioma, and oligoastrocytoma in adults , 2004, Current neurology and neuroscience reports.

[29]  L. Deangelis,et al.  Long-term outcome of low-grade oligodendroglioma and mixed glioma , 2000, Neurology.

[30]  G. Reifenberger,et al.  Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. , 1994, The American journal of pathology.

[31]  B. Scheithauer,et al.  Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype , 1999, Oncogene.

[32]  V. Ganju,et al.  Region‐specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma , 1995, Genes, chromosomes & cancer.